SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-036364
Filing Date
2022-02-11
Accepted
2022-02-11 12:22:05
Documents
2
Group Members
CHRIS HOLLOWOODMARTIN MURPHYSYNCONA HOLDINGS LTDSYNCONA INVESTMENT MANAGEMENT LTDSYNCONA LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G d333525dsc13g.htm SC 13G 128260
2 EX-99.1 d333525dex991.htm EX-99.1 8183
  Complete submission text file 0001193125-22-036364.txt   138249
Mailing Address 2ND FLOOR 8 BLOOMSBURY STREET LONDON X0 WC1B 3SR
Business Address 3RD FLOOR, ARNOLD HOUSE PO BOX 273, ST JULIAN'S AVENUE ST PETER PORT Y7 GY1 3RD 001442039817909
Syncona Portfolio Ltd (Filed by) CIK: 0001725042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y7 | Fiscal Year End: 0331
Type: SC 13G

Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Subject) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92487 | Film No.: 22618469
SIC: 2836 Biological Products, (No Diagnostic Substances)